Table 2.
Cytokine | Normal | Psoriasis | Early MF/CTCL | Late MF/CTCL−B | Late MF/CTCL+B |
---|---|---|---|---|---|
IL-2 | 11943.198* | 27887.483† | 31232.621† | 3059.821‡ | 467.042 |
IL-4 | 295.496§ | 894.575 | 656.166† | 127.036 | 19.571 |
IFN-γ | 4721.754 | 6469.709 | 8093.450† | 1495.562 | 227.792 |
IL-5 | 5.679 | 4.944 | 5.385 | 17.933 | 2.267 |
IL-10 | 9.745‖ | 10.178 | 19.019 | 141.351 | 60.691 |
IL-13 | 340.519¶ | 288.941 | 479.734 | 510.622 | 207.842 |
IL-17 | 96.194‖ | 147.602‖ | 358.714‡ | 238.931 | 46.797 |
P < 0.05 compared with early MF/CTCL, psoriasis, late MF/CTCL+B.
P < 0.05 compared with late MF/CTCL−B, late MF/CTCL+B.
P < 0.05 compared with late MF/CTCL+B.
P < 0.05 compared with early MF/CTCL, late MF/CTCL+B.
P < 0.05 compared with early MF/CTCL.
P < 0.05 compared with late MF/CTCL−B.